• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Healthcare M&A Survey: Health IT Represents the Richest Opportunity in Sector

by Fred Pennic 05/29/2019 Leave a Comment

 

Healthcare M&A Survey: Health IT Represents the Richest Opportunity in Sector

Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.

According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive direction in the next year. This is a 12% jump from the results of the November Merrill Insight poll, where 40% of respondents anticipated a positive outlook and 48% believed the market was headed in a neutral direction.

The positive outlook is tempered by 35% of respondents citing political uncertainty as the most likely factor to sink healthcare deals in the next year. This concern came ahead of investor confidence (22%), data privacy (21%), antitrust / competition (14%) and national security regulations (6%).

Health IT Biggest Opportunity in Sector

The poll finds that 44% of respondents said healthcare IT represented the richest investment opportunity in the sector, ahead of next generation sequencing (22%), medical marijuana (20%) and both point of care delivery and immunotherapy (19%). Technology will drive the most opportunity in population health and precision medicine, according to 25% of respondents. Other areas of opportunity included diagnostics and devices (24%), biosensors and trackers (20%), telehealth (18%) and infrastructure and operations (10%). However, 40% of respondents said data connectivity is the greatest obstacle to harnessing the technology opportunity, followed by technology and healthcare collaboration (23%), lack of user experience focus (14%), technology-as-a-cost-center culture (12%) and the technology talent gap (10%).

“This aligns with the steady stream of transaction activity we are seeing from our healthcare and life sciences clients,” said Rusty Wiley, Chief Executive Officer of Merrill Corporation. “The number of projects we are managing is up almost 12% compared to the same time last year. The shift to a technology-based business environment is pushing life sciences and healthcare companies to acquire or form partnerships to build better data and customer-centric capabilities.”

“The healthcare landscape is becoming increasingly difficult for dealmakers to navigate, as the U.S. enters a major election season and questions still surround the details of Brexit,” said Wiley. “On top of this, the healthcare industry is still grappling with how to operationalize and protect vast amounts of data, as well as how to attract the technology talent needed to capture that opportunity.”

Tagged With: Biosensors, Brexit, Health IT, healthcare it, Healthcare Mergers & Acquisitions, Life Sciences, M&A, Medical Marijuana, point of care, Population Health, Precision Medicine, telehealth

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |